Sign in
CompletedNo phase

Interest of tDCS in Help for Supporting Alcohol Abstinence

Key facts

Who runs it
Centre Hospitalier Henri Laborit
Where
France2 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
90 people enrolled
Started
8 Feb 2017
Ended
7 Aug 2025
Type of study
Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
Treatments tested
  • Active tDCS stimulations
  • Sham tDCS
Record updated
13 January 2026

Who can take part

Age
18 years to 70 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 23 criteriaShow less

Who can take part

  • patient aged from 18 to 70 years old
  • patient free, without guardianship
  • absence of epileptic pathology
  • patient affiliated to the french health security or benefiting through a third party
  • signed informed consent after having received a clear and honest information on the study
  • patient with a disorder linked to the use of alcohol (define by the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) classification) clinically evaluated
  • patient requesting for an alcohol withdrawal
  • patient able to read and write

Who cannot take part

  • current psychiatric decompensation (mood disorder, suicide risk, psychotic disorders)
  • history of cranial traumatism
  • patient in emergency condition or unable to give personally her/his consent
  • mental illness syndrome and Korsakoff
  • patient not affiliated to the french health security or not benefiting through a third party
  • woman in reproductive capacity without effective contraception (hormonal/mechanical: per os, injectable, transcutaneous, implantable, intra-uterine device or chirurgical: tubal ligation, hysterectomy, total ovariectomy) or breastfeeding
  • patient hospitalized under duress
  • patient with guardianship
  • somatic complications during the alcohol withdrawal phase
  • patient under benzodiazepines treatment
  • patient with scalp cutaneous lesion
  • patient with intra-cerebral metallic object
  • patient with a pacemaker
  • epileptic pathology
  • another dependence other than alcohol or tobacco

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The aim of the study is to evaluate in patients with alcohol disorder and forehand weaned the efficiency of 10 active tDCS sessions versus 10 sham (placebo) sessions in the support of abstinence at 3 months.

The 2 groups in the trial

  • Active tDCS stimulationsTreatment being tested

    Patients in this arm will receive 10 tDCS active stimulations of 2 mA (1 stimulation per day from Monday to Friday during 2 weeks).

  • Sham tDCSSham treatment, for comparison

    Patients in this arm will receive 10 sham stimulations (1 stimulation per day from Monday to Friday during 2 weeks). As soon as the power will have reached the maximal intensity as in the active arm, the stimulation will be stopped.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
13 January 2026